Accessibility Menu

Shandong Weigao Group Medical Polymer(FRA) UK2

Market Cap€1.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.33
+0.96%
+0.00Today

Shandong Weigao Group Medical Polymer Financials at a Glance

Market Cap

€1.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.04

P/E Ratio

9.09

Dividend

€0.02

Beta (Volatility)

0.18 (Low)

Price

€0.33

Volume

0

Open

€0.33

Previous Close

€0.33

Daily Range

€0.33 - €0.33

52-Week Range

€0.33 - €0.69

Estimated Earnings Date

N/A

UK2 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

13,307

CEO

Rinan Cong, MBA

Website

www.weigaogroup.com

UK2 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

5.64%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

11.00%

Dividend Yield

5.65%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.49B

Volume

0

Avg. Volume

197.773

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Shandong Weigao Group Medical Polymer Performance Analysis

Shandong Weigao Group Medical Polymer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,942,567,45612.1%
20232023-12-31EUR 1,727,142,396-11.1%
20242024-12-31EUR 1,681,120,508-2.7%
20252025-12-31EUR 1,650,356,900-1.8%
Shandong Weigao Group Medical Polymer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.0930.6%
20232023-12-31EUR 0.06-33.0%
20242024-12-31EUR 0.061.0%
20252025-12-31EUR 0.04-25.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€1.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$218.19-0.01%
BIAFbioAffinity Technologies
$6.33+0.39%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.50-0.05%
INTCIntel
$88.88-0.01%

Questions About UK2

What is the current price of Shandong Weigao Group Medical Polymer?

Shandong Weigao Group Medical Polymer is trading at €0.33 per share.

What is the 52-week range for Shandong Weigao Group Medical Polymer?

Over the past 52 weeks, Shandong Weigao Group Medical Polymer has traded between €0.33 and €0.69.

How much debt does Shandong Weigao Group Medical Polymer have?

As of the most recent reporting period, Shandong Weigao Group Medical Polymer reported total debt of €720.44M.

How much cash does Shandong Weigao Group Medical Polymer have on hand?

Shandong Weigao Group Medical Polymer reported €1.09B in cash and cash equivalents in its most recent financial results.

What is Shandong Weigao Group Medical Polymer’s dividend yield?

Shandong Weigao Group Medical Polymer currently has a dividend yield of 5.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services